RYTM - Rhythm Pharmaceuticals EPS beats by $0.10 beats on revenue November, 02 2021 07:02 AM Rhythm Pharmaceuticals Inc. Rhythm Pharmaceuticals (NASDAQ:RYTM): Q3 GAAP EPS of -$0.70 beats by $0.10. Revenue of $1.02M beats by $0.12M. Press Release For further details see: Rhythm Pharmaceuticals EPS beats by $0.10, beats on revenue